Search Share Prices
AZN Shares - AstraZeneca forecasts 2026 sales, profit growth as Q4 meets expectations
AstraZeneca (LON:AZN) projected continued revenue and earnings growth in 2026 on Tuesday, while its results for the fourth quarter came in line with expectations.
Is There An Opportunity With AstraZeneca PLC's (LON:AZN) 46% Undervaluation?
In this article we are going to estimate the intrinsic value of AstraZeneca PLC (LON:AZN) by projecting its future cash flows and then discounting them to today's value. One way to achieve this is by ...
AstraZeneca's (LON:AZN) investors will be pleased with their notable 61% return over the last five years
The main point of investing for the long term is to make money. But more than that, you probably want to see it rise more than the market average. But AstraZeneca PLC (LON:AZN) has fallen short of ...
EU panel backs Enhertu for certain breast cancers
LONDON - AstraZeneca PLC (LON:AZN) and Daiichi Sankyo's Enhertu has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
AstraZeneca's (LON:AZN) investors will be pleased with their respectable 55% return over the last five years
AstraZeneca PLC (LON:AZN) shareholders might be concerned after seeing the share price drop 11% in the last quarter. On the bright side the returns have been quite good over the last half decade.